SCHEMBL3120585

SCHEMBL3120585

CCOc1cc(C(Nc2ccc(C(=O)OC(C)(C)C)cc2)c2cncnc2)ccc1OC(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 9/20 0.42
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 2/20 0.36
F3 P13726 4/20 0.36
F2 P00734 4/20 0.36
F10 P00742 2/20 0.36
PRSS1 P07477 2/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
PDE4A P27815 6/20 0.36
PDE4B Q07343 6/20 0.36
PDE4C Q08493 6/20 0.36
PDE4D Q08499 6/20 0.36
HTT P42858 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3120604 0.91 F7 (0.44) F7LMNAMAPTKMT2AMEN1
SCHEMBL3202700 0.81 LMNA (0.40) LMNAMAPTKMT2AMEN1MAPK1
SCHEMBL3215132 0.79 KMT2A (0.49) LMNAMAPTKMT2AMEN1MAPK1
SCHEMBL3129124 0.77 SMN1; SMN2 (0.37) F7LMNAMAPTKMT2AMEN1
SCHEMBL3120590 0.76 LMNA (0.38) LMNAMAPTKMT2AMEN1MAPK1
SCHEMBL3126123 0.71 HRH4 (0.38) LMNAMAPTKMT2AMEN1MAPK1
SCHEMBL3129614 0.70 PDE4B (0.40) LMNAMAPTKMT2AMEN1MAPK1
SCHEMBL3205372 0.70 ABCG2 (0.42) LMNAMAPTKMT2AMEN1MAPK1
SCHEMBL3215299 0.70 HDAC6 (0.37) LMNAMAPTKMT2AMEN1MAPK1
SCHEMBL3120645 0.69 DGAT2 (0.43) MAPTKMT2AMEN1RAB9APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed
WO-2010003084-A2 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B F7 3964/4885LMNA 3769/4885MAPT 4197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.